Brief: Aptevo Therapeutics Inc Says Qtrly Royalty Revenue Was $2.4 Million
11/05/2021 14:36
May 11 (Reuters) - Aptevo Therapeutics Inc APVO.O :
* APTEVO THERAPEUTICS INC QTRLY ROYALTY REVENUE WAS $2.4
MILLION
* APTEVO THERAPEUTICS INC QTRLY LOSS PER SHARE $1.64
Source text (https://bit.ly/3y4l79t)
Further company coverage: APVO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptevo Therapeutics
See all newsBrief: Aptevo Therapeutics - Enters Amendment No. 6 To Rights Agreement On October 23, 2026 - SEC Filing
U.S. STOCKS ON THE MOVE-Principal Financial Group, NetApp
U.S. STOCKS ON THE MOVE-Genesco, Fervo Energy, Tyson Foods
Aptevo Therapeutics reports early data for blood cancer therapy; shares fall
Aptevo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary